Search results for: Richard Peto
Filter search results
OHE Seminar: Patents, Price Controls, and the Global Diffusion of New Drugs
5 June 2016, 11:00pm
…The results highlight the important role of policy choices in driving access to new products. Iain Cockburn is the Richard C. Shipley Professor in Management at Boston University, and a…
The commercial case for investing in ALS
13 November 2025
…by 10-16 months from symptom onset due to symptom heterogeneity and the absence of reliable biomarkers (Richards, Morren and Pioro, 2020). Only three disease-modifying therapies (DMTs) have been approved to date,…
Three seminars forthcoming at OHE
12 May 2016
…invite here. On the 6th of June at 5pm, Prof Iain Cockburn, Richard C. Shipley Professor in Management at Boston University, and a Research Associate in the Productivity, Innovation and…
Do child QALYs = adult QALYs? Five reasons why they might not
4 February 2020
…Nancy Devlin, University of Melbourne & Senior Fellow, Office of Health Economics. Nancy Devlin, Professor of Health Economics, University of Melbourne & Senior Research Fellow, Office of Health Economics Richard…
OHE at ISPOR Europe 2: Conceptual and Practical Challenges in Judging Value
29 October 2014
…It? Moderator: Adrian Towse (OHE), with.Hans-Georg Eichler (EMA), Richard Bergstrom (EFPIA), Carole Longson (NICE), and Alric Reuther (IQWiG). This plenary will explore whether earlier licensing of products will benefit patients,…
Recommendations for Making Outcome-based Payments a Reality in the NHS: An Application to Cancer Drugs
21 February 2019
…Making Outcome-based payments a reality in the NHS report Emma Greenwood (Director of Policy and Public Affairs, Cancer Research UK), Richard Preece (Executive Lead for Quality, GMHSCP), and Mike Thorpe (Patient…
OHE Achievements in 2018
27 December 2018
…research projects on new reimbursement models. One, funded by IQVIA, considered innovative payment models including multi-indication pricing as an alternative to single prices. Collaborators included Richard Sullivan (King’s College London)….
What are the Economic Implications of Moving Away from Paying a Single Price for a Single Drug?
9 July 2018
…the report published today, for which research funding was provided by IQVIA, OHE authors Amanda Cole, Adrian Towse, and Paula Lorgelly, along with King’s College London collaborator Professor Richard Sullivan,…
OHE at ISPOR 2018
16 May 2018
…this poster – co-authored with OHE’s Patricia Cubi-Molla; Mark Pennington, King’s College London; and Richard Norman, Curtin University – exploring the implications of using the EQ-5D-5L with cancer patients. …